Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A PHASE 1B/2 STUDY OF A NOVEL ANTI-CTLA-4 NEOBODYTM ADG116 MONOTHERAPY AND IN COMBINATION WITH TORIPALIMAB (TORI; ANTI-PD-1 ANTIBODY) IN PATIENTS WITH ADVANCED/METASTATIC SOLID TUMORSopen access
- Authors
- Park, J[Park, John]; Hsien, M[Hsien, Matthew]; Richardson, G[Richardson, Gary]; Tolcher, A[Tolcher, Anthony]; Chon, HJ[Chon, Hong Jae]; Shin, SJ[Shin, Sang Joon]; Lim, HY[Lim, Ho Yeong]; Hamid, A[Hamid, Anis]; Li, D[Li, Daneng]; Shi, K[Shi, Kristine]; Zheng, SM[Zheng, Songmao]; Liu, GZ[Liu, Guizhong]; Li, A[Li, Ai]; Zhu, LY[Zhu, Lvyu]; Dai, R[Dai, Ruby]; Peng, W[Peng, Wei]; Lowe, D[Lowe, Dana]; Luo, P[Luo, Peter]; Zha, JP[Zha, Jiping]
- Issue Date
- Nov-2022
- Publisher
- BMJ PUBLISHING GROUP
- Citation
- JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.10, pp.A785 - A785
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL FOR IMMUNOTHERAPY OF CANCER
- Volume
- 10
- Start Page
- A785
- End Page
- A785
- ISSN
- 2051-1426
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.